-
Pravastatin is the statin with the least interactions with cytochrome P450-(CYP) 3A4 inhibitors.
-
Atenolol is unsuitable as a first-line drug in hypertension.
-
Pharmacotherapy of hypertension has been much in the news in the last 2 months. Standard therapies such as atenolol have been challenged, while calcium channel antagonists may be making a comeback.
-
-
The addition of nifedipine to conventional treatment in patients with chronic stable angina did not affect overall event-free survival, but was safe and reduced the need for coronary interventions.
-
Recurrent MI a major cause of death in post MI left-ventricular
dysfunction patients.
-
Body size is not a significant predictor of CABG mortality.
-
Based on a large national database of heart valve patients, a risk score has been developed to predict operative mortality for any valve surgery.
-
Asymptomatic atrial fibrillation occurs commonly after radiofrequency ablation procedures for atrial fibrillation. Thus, a symptom only based follow-up substantially overestimates the true success rate of AF ablation procedures.
-
This system may be an alternative therapeutic strategy for patients at risk of stroke who have contraindications for long-term warfarin anticoagulation.
